Will you be joining us at the Festival of Biologics in Basel next week? Don’t miss the presentation by our CSO, Michael Thiele, titled “Antibody ON104: Alleviating Inflammation by Neutralizing Key Pathological Functions of oxMIF.” Also, be sure to visit our poster #76, where our Senior Scientist Maroua Ferhat will be showcasing ON104’s efficacy in a mouse arthritis model. It’s an excellent opportunity to delve into the promising potential of our leading candidate, the anti-oxMIF antibody ON104, as an innovative treatment for autoimmune diseases.”